Medpace Holdings Inc (MEDP)
389.34
-3.94
(-1.00%)
USD |
NASDAQ |
May 17, 12:27
Medpace Holdings Max Drawdown (5Y): 42.87% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 42.87% |
| March 31, 2024 | 42.87% |
| February 29, 2024 | 42.87% |
| January 31, 2024 | 42.87% |
| December 31, 2023 | 42.87% |
| November 30, 2023 | 42.87% |
| October 31, 2023 | 42.87% |
| September 30, 2023 | 42.87% |
| August 31, 2023 | 42.87% |
| July 31, 2023 | 42.87% |
| June 30, 2023 | 42.87% |
| May 31, 2023 | 42.87% |
| April 30, 2023 | 42.87% |
| March 31, 2023 | 42.87% |
| February 28, 2023 | 42.87% |
| January 31, 2023 | 42.87% |
| December 31, 2022 | 42.87% |
| November 30, 2022 | 42.87% |
| October 31, 2022 | 42.87% |
| September 30, 2022 | 42.87% |
| August 31, 2022 | 42.87% |
| July 31, 2022 | 42.87% |
| June 30, 2022 | 42.87% |
| May 31, 2022 | 42.87% |
| April 30, 2022 | 42.87% |
| Date | Value |
|---|---|
| March 31, 2022 | 39.47% |
| February 28, 2022 | 41.43% |
| January 31, 2022 | 41.43% |
| December 31, 2021 | 41.43% |
| November 30, 2021 | 41.43% |
| October 31, 2021 | 41.43% |
| September 30, 2021 | 41.43% |
| August 31, 2021 | 41.43% |
| July 31, 2021 | 41.43% |
| June 30, 2021 | 41.43% |
| May 31, 2021 | 41.43% |
| April 30, 2021 | 41.43% |
| March 31, 2021 | 41.43% |
| February 28, 2021 | 41.43% |
| January 31, 2021 | 41.43% |
| December 31, 2020 | 41.43% |
| November 30, 2020 | 41.43% |
| October 31, 2020 | 41.43% |
| September 30, 2020 | 41.43% |
| August 31, 2020 | 41.43% |
| July 31, 2020 | 41.43% |
| June 30, 2020 | 41.43% |
| May 31, 2020 | 41.43% |
| April 30, 2020 | 41.43% |
| March 31, 2020 | 41.43% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
39.47%
Minimum
Mar 2022
42.87%
Maximum
Apr 2022
42.00%
Average
41.43%
Median
May 2019
Max Drawdown (5Y) Benchmarks
| Charles River Laboratories International Inc | 64.10% |
| Avid Bioservices Inc | 86.42% |
| Iovance Biotherapeutics Inc | 93.72% |
| Renovaro Inc | 96.81% |
| Candel Therapeutics Inc | -- |